Him Teknoforge Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 30, 2025, 12:22 am

Quick Insight

Him Teknoforge Ltd, operating in the Auto Ancl – Gears & Drive sector, presents a mixed financial picture. With a P/E ratio of 18.0 and ROE and ROCE at 4.93% and 9.33% respectively, the company's profitability metrics are somewhat underwhelming. However, the OPM stands at 9.71%, indicating operational efficiency. The company's low P/BV ratio of 0.68x suggests the stock may be undervalued, while a healthy ICR of 2.26x provides a cushion for meeting interest obligations. The high CCC of 247 days warrants attention, signaling potential liquidity challenges. Investors should closely monitor operational improvements and cash flow management to gauge the company's future performance accurately.

Competitors of Him Teknoforge Ltd

All Competitor Stocks of Him Teknoforge Ltd

Quarterly Result

Last Updated: August 19, 2025, 1:50 pm

Below is a detailed analysis of the quarterly data for Him Teknoforge Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 100.71 Cr.. The value appears to be declining and may need further review. It has decreased from 106.61 Cr. (Mar 2025) to 100.71 Cr., marking a decrease of 5.90 Cr..
• For Expenses, as of Jun 2025, the value is 90.93 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 96.85 Cr. (Mar 2025) to 90.93 Cr., marking a decrease of 5.92 Cr..
• For Operating Profit, as of Jun 2025, the value is 9.78 Cr.. The value appears strong and on an upward trend. It has increased from 9.76 Cr. (Mar 2025) to 9.78 Cr., marking an increase of 0.02 Cr..
• For OPM %, as of Jun 2025, the value is 9.71%. The value appears strong and on an upward trend. It has increased from 9.15% (Mar 2025) to 9.71%, marking an increase of 0.56%.
• For Other Income, as of Jun 2025, the value is 1.04 Cr.. The value appears to be declining and may need further review. It has decreased from 1.13 Cr. (Mar 2025) to 1.04 Cr., marking a decrease of 0.09 Cr..
• For Interest, as of Jun 2025, the value is 4.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.36 Cr. (Mar 2025) to 4.39 Cr., marking an increase of 0.03 Cr..
• For Depreciation, as of Jun 2025, the value is 2.64 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.72 Cr. (Mar 2025) to 2.64 Cr., marking a decrease of 0.08 Cr..
• For Profit before tax, as of Jun 2025, the value is 3.79 Cr.. The value appears to be declining and may need further review. It has decreased from 3.81 Cr. (Mar 2025) to 3.79 Cr., marking a decrease of 0.02 Cr..
• For Tax %, as of Jun 2025, the value is 24.27%. The value appears to be increasing, which may not be favorable. It has increased from -8.40% (Mar 2025) to 24.27%, marking an increase of 32.67%.
• For Net Profit, as of Jun 2025, the value is 2.87 Cr.. The value appears to be declining and may need further review. It has decreased from 4.13 Cr. (Mar 2025) to 2.87 Cr., marking a decrease of 1.26 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.03. The value appears to be declining and may need further review. It has decreased from 4.36 (Mar 2025) to 3.03, marking a decrease of 1.33.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 12:57 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:07 pm

Below is a detailed analysis of the balance sheet data for Him Teknoforge Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For Reserves, as of Mar 2025, the value is 218.00 Cr.. The value appears strong and on an upward trend. It has increased from 178.00 Cr. (Mar 2024) to 218.00 Cr., marking an increase of 40.00 Cr..
• For Borrowings, as of Mar 2025, the value is 150.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 149.00 Cr. (Mar 2024) to 150.00 Cr., marking an increase of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 83.00 Cr.. The value appears to be improving (decreasing). It has decreased from 84.00 Cr. (Mar 2024) to 83.00 Cr., marking a decrease of 1.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 453.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 414.00 Cr. (Mar 2024) to 453.00 Cr., marking an increase of 39.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 186.00 Cr.. The value appears strong and on an upward trend. It has increased from 178.00 Cr. (Mar 2024) to 186.00 Cr., marking an increase of 8.00 Cr..
• For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 2.00 Cr., marking an increase of 2.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 265.00 Cr.. The value appears strong and on an upward trend. It has increased from 236.00 Cr. (Mar 2024) to 265.00 Cr., marking an increase of 29.00 Cr..
• For Total Assets, as of Mar 2025, the value is 453.00 Cr.. The value appears strong and on an upward trend. It has increased from 414.00 Cr. (Mar 2024) to 453.00 Cr., marking an increase of 39.00 Cr..

Notably, the Reserves (218.00 Cr.) exceed the Borrowings (150.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Him Teknoforge Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 11.67. This value is within the healthy range. It has increased from 9.04 (Mar 24) to 11.67, marking an increase of 2.63.
• For Diluted EPS (Rs.), as of Mar 25, the value is 11.67. This value is within the healthy range. It has increased from 9.04 (Mar 24) to 11.67, marking an increase of 2.63.
• For Cash EPS (Rs.), as of Mar 25, the value is 21.42. This value is within the healthy range. It has increased from 21.39 (Mar 24) to 21.42, marking an increase of 0.03.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 232.69. It has increased from 228.85 (Mar 24) to 232.69, marking an increase of 3.84.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 232.69. It has increased from 228.85 (Mar 24) to 232.69, marking an increase of 3.84.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 0.40 (Mar 24) to 0.00, marking a decrease of 0.40.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 425.46. It has decreased from 474.74 (Mar 24) to 425.46, marking a decrease of 49.28.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 44.34. This value is within the healthy range. It has decreased from 46.94 (Mar 24) to 44.34, marking a decrease of 2.60.
• For PBIT / Share (Rs.), as of Mar 25, the value is 33.22. This value is within the healthy range. It has decreased from 34.59 (Mar 24) to 33.22, marking a decrease of 1.37.
• For PBT / Share (Rs.), as of Mar 25, the value is 13.63. This value is within the healthy range. It has increased from 12.34 (Mar 24) to 13.63, marking an increase of 1.29.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 10.30. This value is within the healthy range. It has increased from 9.04 (Mar 24) to 10.30, marking an increase of 1.26.
• For PBDIT Margin (%), as of Mar 25, the value is 10.42. This value is within the healthy range. It has increased from 9.88 (Mar 24) to 10.42, marking an increase of 0.54.
• For PBIT Margin (%), as of Mar 25, the value is 7.80. This value is below the healthy minimum of 10. It has increased from 7.28 (Mar 24) to 7.80, marking an increase of 0.52.
• For PBT Margin (%), as of Mar 25, the value is 3.20. This value is below the healthy minimum of 10. It has increased from 2.59 (Mar 24) to 3.20, marking an increase of 0.61.
• For Net Profit Margin (%), as of Mar 25, the value is 2.42. This value is below the healthy minimum of 5. It has increased from 1.90 (Mar 24) to 2.42, marking an increase of 0.52.
• For Return on Networth / Equity (%), as of Mar 25, the value is 4.42. This value is below the healthy minimum of 15. It has increased from 3.95 (Mar 24) to 4.42, marking an increase of 0.47.
• For Return on Capital Employeed (%), as of Mar 25, the value is 11.67. This value is within the healthy range. It has increased from 11.22 (Mar 24) to 11.67, marking an increase of 0.45.
• For Return On Assets (%), as of Mar 25, the value is 2.15. This value is below the healthy minimum of 5. It has increased from 1.71 (Mar 24) to 2.15, marking an increase of 0.44.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 0.2. It has decreased from 0.27 (Mar 24) to 0.16, marking a decrease of 0.11.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.68. This value is within the healthy range. It has decreased from 0.83 (Mar 24) to 0.68, marking a decrease of 0.15.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.92. It has decreased from 0.94 (Mar 24) to 0.92, marking a decrease of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 1.5. It has increased from 1.33 (Mar 24) to 1.38, marking an increase of 0.05.
• For Quick Ratio (X), as of Mar 25, the value is 0.47. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.47, marking an increase of 0.10.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.36. This value is below the healthy minimum of 4. It has decreased from 1.38 (Mar 24) to 1.36, marking a decrease of 0.02.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 4.42 (Mar 24) to 0.00, marking a decrease of 4.42.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 1.87 (Mar 24) to 0.00, marking a decrease of 1.87.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 95.58 (Mar 24) to 0.00, marking a decrease of 95.58.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 98.13 (Mar 24) to 0.00, marking a decrease of 98.13.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.26. This value is below the healthy minimum of 3. It has increased from 2.11 (Mar 24) to 2.26, marking an increase of 0.15.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.53. This value is below the healthy minimum of 3. It has increased from 1.41 (Mar 24) to 1.53, marking an increase of 0.12.
• For Enterprise Value (Cr.), as of Mar 25, the value is 298.40. It has increased from 242.95 (Mar 24) to 298.40, marking an increase of 55.45.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.74, marking an increase of 0.09.
• For EV / EBITDA (X), as of Mar 25, the value is 7.11. This value is within the healthy range. It has increased from 6.58 (Mar 24) to 7.11, marking an increase of 0.53.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has increased from 0.25 (Mar 24) to 0.37, marking an increase of 0.12.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 95.57 (Mar 24) to 0.00, marking a decrease of 95.57.
• For Price / BV (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.53 (Mar 24) to 0.68, marking an increase of 0.15.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has increased from 0.25 (Mar 24) to 0.37, marking an increase of 0.12.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.06, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness